CPHI vs DHR · rev $4.1M vs P/E 39, rev $24.57B
China Pharma Holdings Inc (CPHI) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
CPHI currently screens at market cap $29.0M. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the CPHI and DHR stock pages for the full models.
Not investment advice.